NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Athera Biotechnologies AB

Athera Biotechnologies AB

Private
StockholmHealthcare & Life Scienceshttps://athera.se

Last Round

VC Round

May 21, 2019

Company Overview

Athera Biotechnologies AB is a biotechnology company that develops targeted anti-inflammatory biological candidate drugs for the prevention and treatment of cardiovascular and immunovascular diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologymonoclonal antibodyvascular inflammationatherosclerosiscardiovascular diseasebiomarkerdiagnostic assaydrug developmentclinical stage biotechtherapeutic developmentprecision medicinebiopharmadrug discoveryELISAout-licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Athera Biotechnologies AB Comparables

Compare Athera Biotechnologies AB with similar companies based on industry and business-model similarity.

Athera Biotechnologies AB comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Abcentra
84%
Marea Therapeutics
74%
Beijing Sungen Biomedical Technology Co., Ltd.
71%

Athera Biotechnologies AB Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundMay 21, 2019
VC RoundAug 29, 2017
VC RoundDec 3, 2015

Athera Biotechnologies AB Investors

Notable investors and investment history

Athera Biotechnologies AB investors
InvestorRounds
IndustrifondenVC Round
The Foundation for Baltic and East European StudiesVC Round
Linc ABVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 29, 2017

    $7M raised from Linc AB, Industrifonden, and others.

  • Dec 3, 2015

    $3M round led by Industrifonden and The Foundation for Baltic and East European Studies.

Athera Biotechnologies AB Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Athera Biotechnologies AB Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Athera Biotechnologies AB's valuation, stock price, and market status.

Firmographic Details

HeadquartersStockholm
Employee Range1
Year Founded2003
Last FundingMay 21, 2019

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.